Eiko Lifesciences Ltd vs Shreyas Intermediates Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Eiko Lifesciences Ltd is ₹ 53.65 as of 18 Mar 15:30 . The P/E Ratio of Eiko Lifesciences Ltd is 31.1 as of March 2025 .The P/E Ratio of Shreyas Intermediates Ltd is 0 as of March 2025 . The Market Cap of Eiko Lifesciences Ltd is ₹ 65.15 crore as of March 2025 .The Market Cap of Shreyas Intermediates Ltd is ₹ 0 crore as of March 2025 . The revenue of Eiko Lifesciences Ltd for the Dec '25 is ₹ 12.33 crore as compare to the Sep '25 revenue of ₹ 11.97 crore. This represent the growth of 3.01% The revenue of Shreyas Intermediates Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Eiko Lifesciences Ltd for the Dec '25 is ₹ 2.22 crore as compare to the Sep '25 ebitda of ₹ 2.07 crore. This represent the growth of 7.25% The ebitda of Shreyas Intermediates Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Eiko Lifesciences Ltd changed from ₹ 0.35 crore to ₹ 1.43 crore over 7 quarters. This represents a CAGR of 123.51% The net profit of Shreyas Intermediates Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Eiko Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Shreyas Intermediates Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Eiko Lifesciences Ltd

Eiko Lifesciences Limited was originally incorporated on January 07, 1977, under the name Narendra Investments (Delhi) Limited.
Later, the Company changed its name from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited effective from June 24, 2021.
Earlier, the Company engaged in sale and purchase of shares and securities.
At present, the Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally. The Company commenced new business activity primarily in manufacturing of speciality and fine chemicals in October, 2020 from manufacturing facility located at Badlapur, Maharashtra and has since scaled its operations, grown brand and customer base to become the one of the fastest growing speciality chemicals companies in India.

About Shreyas Intermediates Ltd

Shreyas Intermediates Limited (SIL) was incorporated as a Private Limited Company on November 6, 1989 and subsequently converted into a Public Limited Company in April, 1992.
The Company was promoted by Dinesh S Sharma.
The Company is engaged in manufacturing of Dyes, Pigments and Pigment Intermediates. In Dec.'93, the company came out with its initial public offering, aggregating Rs 3.29 Cr, to diversify into the manufacture of Copper Phthalocyanine Blue Crude and Copper Phthalocyanine Green, with a capacity of 540 TPA and 321 TPA respectively.
The estimated cost of the project was Rs 8.60 Cr.
Both the products have good export potential especially in the US and Germany. The products of SIL find application in the manufacture of plastic colours, direct colours, inks, rubber paints and in the paint industry.

FAQs for the comparison of Eiko Lifesciences Ltd and Shreyas Intermediates Ltd

Which company has a larger market capitalization, Eiko Lifesciences Ltd or Shreyas Intermediates Ltd?

Market cap of Eiko Lifesciences Ltd is 76 Cr while Market cap of Shreyas Intermediates Ltd is 46 Cr

What are the key factors driving the stock performance of Eiko Lifesciences Ltd and Shreyas Intermediates Ltd?

The stock performance of Eiko Lifesciences Ltd and Shreyas Intermediates Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Eiko Lifesciences Ltd and Shreyas Intermediates Ltd?

As of March 18, 2026, the Eiko Lifesciences Ltd stock price is INR ₹53.65. On the other hand, Shreyas Intermediates Ltd stock price is INR ₹6.63.

How do dividend payouts of Eiko Lifesciences Ltd and Shreyas Intermediates Ltd compare?

To compare the dividend payouts of Eiko Lifesciences Ltd and Shreyas Intermediates Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.